HALKUFF DAWN

SEC Form 4 insider trading activity

HALKUFF DAWN has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.

On the most recent filing, HALKUFF DAWN is listed as Director at Xeris Biopharma Holdings, Inc. Inside the rolling window, HALKUFF DAWN reported no open-market purchases and 1 open-market sale totaling $122K in XERS.

Companies traded

Other insiders at XERS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$122K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
XERS
HALKUFF DAWN
Sale$122KJun 5SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has HALKUFF DAWN made?

HALKUFF DAWN has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.

Which companies does HALKUFF DAWN trade?

HALKUFF DAWN has filed SEC Form 4 disclosures for 1 company, including XERS.

When was HALKUFF DAWN's most recent SEC Form 4 filing?

HALKUFF DAWN's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.

What is HALKUFF DAWN's total buy and sell value in the current window?

Inside the rolling retention window, HALKUFF DAWN bought $0 and sold $122K based on SEC Form 4 filings.

What was HALKUFF DAWN's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 20,000 XERS shares on 2026-06-04, worth $122K, per SEC Form 4 filings.